Tonix Pharmaceuticals Holding Stock In The News

TNXP Stock  USD 15.00  1.36  9.97%   
Our overall analysis of Tonix Pharmaceuticals' news coverage and content from conventional and social sources shows investors' bearish mood towards Tonix Pharmaceuticals Holding. The specific impact of Tonix Pharmaceuticals news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Tonix Pharmaceuticals' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Tonix Pharmaceuticals headlines in addition to utilizing other, more conventional financial analysis modules. Check out Tonix Pharmaceuticals Backtesting and Tonix Pharmaceuticals Hype Analysis.

Tonix Pharmaceuticals Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
https://www.globenewswire.com/news-release/2025/03/14/3042975/0/en/Life-Science-Virtual-Investor-Forum-Presentations-Now-Available-for-Online-Viewing.html
 Bullish
Macroaxis News: globenewswire.com
Life Sciences Investor Forum Agenda Announced for March 13th
https://www.globenewswire.com/news-release/2025/03/12/3041653/0/en/Life-Sciences-Investor-Forum-Agenda-Announced-for-March-13th.html
 Bullish
Macroaxis News: globenewswire.com
Tonix Pharmaceuticals to Present at the Zacks SCR Life Sciences Virtual Investor Forum on March 13th
https://www.globenewswire.com/news-release/2025/03/11/3040395/28908/en/Tonix-Pharmaceuticals-to-Present-at-the-Zacks-SCR-Life-Sciences-Virtual-Investor-Forum-on-March-13th.html
 Neutral
Yahoo News
Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared on Thursday
https://finance.yahoo.com/news/why-tonix-pharmaceuticals-holding-corp-184046386.html
 Neutral
Macroaxis News: globenewswire.com
Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash
https://www.globenewswire.com/news-release/2025/02/07/3022788/28908/en/Tonix-Pharmaceuticals-Recently-Announced-Preliminary-Full-Year-2024-Operating-Results-and-Year-End-Cash.html
 Neutral
Macroaxis News: globenewswire.com
Tonix Pharmaceuticals Announces Positive...
https://www.globenewswire.com/news-release/2025/02/06/3021973/28908/en/Tonix-Pharmaceuticals-Announces-Positive-Topline-Results-from-Phase-1-Trial-for-TNX-1500-a-Next-Generation-anti-CD40L-mAb-Candidate-for-Prevention-of-Kidney-Transplant-Rejection-an.html
 Neutral
Macroaxis News: globenewswire.com
Tonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor Conference
https://www.globenewswire.com/news-release/2025/02/05/3021037/28908/en/Tonix-Pharmaceuticals-to-Participate-in-the-2025-BIO-CEO-Investor-Conference.html
 Neutral
Macroaxis News: globenewswire.com
Tonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical Officer
https://www.globenewswire.com/news-release/2025/02/04/3020135/28908/en/Tonix-Pharmaceuticals-Promotes-Siobhan-Fogarty-to-Chief-Technical-Officer.html
 Neutral
Macroaxis News: globenewswire.com
Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
https://www.globenewswire.com/news-release/2025/02/03/3019492/28908/en/Tonix-Pharmaceuticals-Announces-1-for-100-Reverse-Stock-Split.html
 Neutral
Yahoo News
7 F-Rated Stocks To Sell in July
https://finance.yahoo.com/news/7-f-rated-stocks-sell-110000086.html
 Bullish

Tonix Pharmaceuticals Holding Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Tonix and other traded companies coverage with news coverage. We help investors stay connected with Tonix headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Tonix Stock performance. Please note that trading solely based on the Tonix Pharmaceuticals Holding hype is not for everyone as timely availability and quick action are needed to avoid losses.
Tonix Pharmaceuticals' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Tonix Pharmaceuticals Holding investors visualize upcoming and past events in order to time the market based on Tonix Pharmaceuticals Holding noise-free hype analysis.
Tonix Pharmaceuticals stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Tonix earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Tonix Pharmaceuticals that are available to investors today. That information is available publicly through Tonix media outlets and privately through word of mouth or via Tonix internal channels. However, regardless of the origin, that massive amount of Tonix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tonix Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tonix Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tonix Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tonix Pharmaceuticals alpha.

Tonix Largest EPS Surprises

Earnings surprises can significantly impact Tonix Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-13
2024-03-31-0.39-0.180.2153 
2022-08-08
2022-06-30-1.44-1.220.2215 
2023-03-13
2022-12-31-0.86-0.560.334 
2022-03-14
2021-12-31-1.92-2.24-0.3216 
2022-11-07
2022-09-30-1.02-0.690.3332 
2023-11-09
2023-09-30-1.49-1.83-0.3422 
View All Earnings Estimates

Tonix Pharmaceuticals Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Tonix Pharmaceuticals Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
13th of March 2025
Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring 2025
at gurufocus.com 
Gurufocus Stories at Macroaxis
11th of March 2025
Acquisition by Olukotun Adeoye Y of 2131500 shares of Tonix Pharmaceuticals at 0.132 subje...
at gurufocus.com 
Macroaxis News: globenewswire.com
10th of March 2025
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium for Development o...
at globenewswire.com 
Yahoo News
7th of March 2025
Why Tonix Pharmaceuticals Holding Corp. Soared on Thursday
at finance.yahoo.com 
Yahoo News
6th of March 2025
Tonix Surges 31 percent Following Positive Phase 3 Fibromyalgia Drug Trial Results
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
5th of March 2025
Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit
at gurufocus.com 
Yahoo News
3rd of March 2025
Global Artificial Intelligence in Drug Commercialization Market to Observe Stupendous Grow...
at finance.yahoo.com 
news
26th of February 2025
Tonix Pharmaceuticals Shares Down 6.6 percent Heres Why
at thelincolnianonline.com 
Yahoo News
24th of February 2025
TNXP PDUFA Date for TNX-102 SL in Fibromyalgia of August 15, 2025
at finance.yahoo.com 
benzinga news
7th of February 2025
Whats Going On With Tonix Pharmaceuticals Shares Friday
at benzinga.com 
Marketbeat News
30th of January 2025
Is Tonix Pharmaceuticals the Next Biotech Breakout
at marketbeat.com 
Investing News at Macroaxis
20th of December 2024
Tonix Pharmaceuticals ups offering to 250 million
at investing.com 

Tonix Pharmaceuticals Investors Sentiment

The influence of Tonix Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Tonix. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Tonix Pharmaceuticals' public news can be used to forecast risks associated with an investment in Tonix. The trend in average sentiment can be used to explain how an investor holding Tonix can time the market purely based on public headlines and social activities around Tonix Pharmaceuticals Holding. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Tonix Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Tonix Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Tonix Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Tonix Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tonix Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tonix Pharmaceuticals' short interest history, or implied volatility extrapolated from Tonix Pharmaceuticals options trading.

Additional Tools for Tonix Stock Analysis

When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.